The stability of the proportion of HSPCs/CD34 in SCD patients that we nevertheless observed, therefore suggests that the mechanisms that control the proportion of HSPCs in the circulation were quite robust. This evidence concerns the gene CD34 and Schnyder corneal dystrophy.